Changmao Biochemical Engineering Company Limited (HKG:0954)

Hong Kong · Delayed Price · Currency is HKD

0.3250

+0.0150 (4.84%)

Jun 12, 2026, 1:50 PM HKT

10.17% (1Y)

Market Cap	172.15M +16.1%
Revenue (ttm)	619.75M -4.8%
Net Income	-74.29M
EPS	-0.14
Shares Out	529.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,000
Open	0.3250
Previous Close	0.3100
Day's Range	0.3250 - 0.3250
52-Week Range	0.2650 - 0.3600
Beta	0.41
Analysts	Hold
Price Target	2.97 (+813.85%)
Earnings Date	Aug 17, 2026

About HKG:0954

Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, the United States, and internationally. The company offers maleic anhydride, fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L (+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, medical intermediaries, pharmaceutical adjuvant, active pharm... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1992

Employees 509

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 0954

Full Company Profile

Financial Performance

In 2025, HKG:0954's revenue was 556.93 million, a decrease of -4.77% compared to the previous year's 584.79 million. Losses were -66.76 million, -2.17% less than in 2024.

Financial numbers in CNY Financial Statements